Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Anticancer Research|July 3, 2019
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case ReportMichele Massimino, Stefania Stella, Elena Tirrò, et al.
Critical Reviews in Oncology/Hematology|August 5, 2026
Revisiting Diffuse Gliomas in the Era of Precision Medicine: Molecular Insights and Therapeutic ImplicationsMichele Massimino, Stefania Stella, Giuseppe Di Grazia, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|May 29, 2012
8-isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot studySavino Sciascia, Dario Roccatello, Maria Tiziana Bertero, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|November 6, 2024
[Biomarkers and Bone Turnover Markers in Chronic Kidney Disease - Mineral and Bone Disorders (CKD-MBD): Recent Advances]Althea Cossettini, Giulia Vanessa Re Sartò, Andrea Aghi, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia PatientsStefania Stella, Silvia Rita Vitale, Fabio Stagno, et al.
Frontiers in Oncology|February 19, 2021
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in GlioblastomaElena Tirrò, Michele Massimino, Chiara Romano, et al.
Chemotherapy|October 30, 2018
Long-Term Molecular Remission Achieved by Antibody Anti-CD22 and Ponatinib in a Patient Affected by Ph'+ Acute Lymphoblastic Leukemia Relapsed after Second Allogeneic Hematopoietic Stem Cell Transplantation: A Case ReportMaria Cristina Pirosa, Salvatore Leotta, Alessandra Cupri, et al.
Frontiers in Pharmacology|July 19, 2021
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 TranscriptsMichele Massimino, Elena Tirrò, Stefania Stella, et al.
International Journal of Molecular Sciences|March 13, 2025
No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript LevelFabio Stagno, Stefania Stella, Salvatore Leotta, et al.
Genes|September 22, 2019
Molecular Alterations in Thyroid Cancer: From Bench to Clinical PracticeElena Tirrò, Federica Martorana, Chiara Romano, et al.
Pageof 9